A new era for endometrial cancer: Treatment advances transforming care

Join us for the first Royal Society of Medicine event dedicated to endometrial cancer.

There has been progress in our molecular knowledge of the disease and multi-disciplinary treatment of endometrial cancer in recent years. In the last year, landmark clinical trials are changing clinical practice integrating molecular testing and immunotherapy in treatment decisions. This meeting will provide an overview of the latest cutting-edge results setting new standards in endometrial cancer management, including updates on staging, pathology and molecular testing, surgery, radiotherapy and drug treatments.

Our multi-disciplinary faculty of national and international experts will provide in-depth presentations and discussions on controversial areas to guide the best clinical practice for women with endometrial cancer.

By attending, you will:

• Understand the rising incidence, survival, disparities and prevention strategies for endometrial cancer
• Be able to make multidisciplinary decisions integrating staging and molecular status in early and advanced/recurrent endometrial cancer
• Understand the latest immunotherapy clinical trials changing practice in endometrial cancer
• Recognise and manage treatment-related toxicities of immunotherapy and targeted therapies in endometrial cancer
• Improve knowledge of the latest advances and future perspectives in endometrial cancer treatment